Cardiovascular Diseases Clinical Trial
Official title:
Early Mobilization of Older Adults in the Cardiovascular Intensive Care Unit
NCT number | NCT03616873 |
Other study ID # | 17-188 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | February 22, 2018 |
Est. completion date | April 30, 2020 |
Verified date | October 2020 |
Source | Lady Davis Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
An early mobilization (EM) program will be implemented in the Cardiovascular Intensive Care
Unit at the Jewish General Hospital (JGH), an academic tertiary hospital in Montreal, Quebec.
The investigators will perform a prospective, pre/post-EM intervention study in adults aged
≥60 years old admitted to the Cardiovascular Intensive Care Unit (CICU) at the JGH. During a
3-month period, the investigators will prospectively enrol patients to the pre-intervention
cohort. The EM intervention will then be implemented. During a 12-month period, the
investigators will prospectively enrol patients to the intervention cohort. 1 and 12 months
following hospital discharge, patients in the pre-intervention and post-intervention cohorts
will be contacted by phone by a member of the research team to assess for functional status
and quality of life measures.
The primary effectiveness outcome will be the mean improvement in level of function (LOF)
during CICU admission and at 1 and 12 months. Covariates predicting improvement in LOF
("responsiveness") and ones which do not ("non-responsiveness") will be assessed. The
recovery of physical function at 1 month and 6 months as measured by the SF-36 physical
component summary score will be assessed. The SF-36 scores of the highest scoring tertile of
LOF on hospital discharge will be compared with the lowest scoring tertile. Hospital
readmission at 30 days and discharge home vs. healthcare facility will also be compared. For
safety, the composite and individual components of the number of falls, injuries, and
dislodgements over the total number of attempted mobility activities will be recorded. The
results from the intervention cohort will be compared to the pre-intervention cohort for all
results.
Status | Completed |
Enrollment | 147 |
Est. completion date | April 30, 2020 |
Est. primary completion date | April 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years and older |
Eligibility |
Inclusion Criteria: - Participating in early mobilization program - Age 60 years old or older Exclusion Criteria: - CICU stays less than 24 hours - Patients with prehospital LOF 0 (immobile), LOF 1 (bedbound) or 2 (can sit in chair only). - Cardiac surgery patients will also be excluded. |
Country | Name | City | State |
---|---|---|---|
Canada | Jewish General Hospital / Lady Davis Institute | Montréal | Quebec |
Lead Sponsor | Collaborator |
---|---|
Lady Davis Institute | Jewish General Hospital |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean change in Level of Function (LOF) scale score during CICU admission and 1 and 12 months post-hospitalization | The mean improvement change in the Level of Function scale score in patients undergoing early mobilization. The Level of Function scale measures mobility and ranges from 0 (bed immobile) to 5 (walking more than 20 meters), with higher scores indicating better mobility. | Duration of Cardiac Intensive Care Unit stay (average 4 days) and 1 and 12 months post-hosptialization | |
Secondary | Recovery of physical function | Recovery of physical function at 1 month and 12 months as measured by the Short Form (SF)-36 physical component summary score (measures 8 subscales: physical functioning, physical role, bodily pain, general health, vitality, social functioning, emotional role and mental health). The score range is from 0 to 100 and scores are calibrated so that 50 is the average score. Higher scores mean less disability. | 1 month and 12 months. | |
Secondary | Recovery of functional ability | The recovery of functional ability at 1 month and 12 months as measured by the Level of Function scale score. The Level of Function scale measures mobility and ranges from 0 (bed immobile) to 5 (walking more than 20 meters), with higher scores indicating better mobility. | 1 month and 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|